Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators.
Publication
, Journal Article
Working Group on Functional Outcome Measures for Clinical Trials, ; Bhasin, S; Espeland, MA; Evans, WJ; Ferrucci, L; Fried, LP; Gill, TM; Pahor, M ...
Published in: J Gerontol A Biol Sci Med Sci
April 2009
Duke Scholars
Published In
J Gerontol A Biol Sci Med Sci
DOI
EISSN
1758-535X
Publication Date
April 2009
Volume
64
Issue
4
Start / End Page
487 / 491
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Sensitivity and Specificity
- Risk Assessment
- Research
- Practice Guidelines as Topic
- Physical Fitness
- Pharmaceutical Preparations
- Outcome Assessment, Health Care
- Male
Citation
APA
Chicago
ICMJE
MLA
NLM
Working Group on Functional Outcome Measures for Clinical Trials, ., Bhasin, S., Espeland, M. A., Evans, W. J., Ferrucci, L., Fried, L. P., … Parks, M. (2009). Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. J Gerontol A Biol Sci Med Sci, 64(4), 487–491. https://doi.org/10.1093/gerona/gln042
Working Group on Functional Outcome Measures for Clinical Trials, Mary, Shalender Bhasin, Mark A. Espeland, William J. Evans, Luigi Ferrucci, Linda P. Fried, Thomas M. Gill, et al. “Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators.” J Gerontol A Biol Sci Med Sci 64, no. 4 (April 2009): 487–91. https://doi.org/10.1093/gerona/gln042.
Working Group on Functional Outcome Measures for Clinical Trials, Bhasin S, Espeland MA, Evans WJ, Ferrucci L, Fried LP, et al. Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. J Gerontol A Biol Sci Med Sci. 2009 Apr;64(4):487–91.
Working Group on Functional Outcome Measures for Clinical Trials, Mary, et al. “Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators.” J Gerontol A Biol Sci Med Sci, vol. 64, no. 4, Apr. 2009, pp. 487–91. Pubmed, doi:10.1093/gerona/gln042.
Working Group on Functional Outcome Measures for Clinical Trials, Bhasin S, Espeland MA, Evans WJ, Ferrucci L, Fried LP, Gill TM, Pahor M, Studenski S, Guralnik J, Nayfield S, Romashkin S, Perlstein R, Burke L, Parks M. Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. J Gerontol A Biol Sci Med Sci. 2009 Apr;64(4):487–491.
Published In
J Gerontol A Biol Sci Med Sci
DOI
EISSN
1758-535X
Publication Date
April 2009
Volume
64
Issue
4
Start / End Page
487 / 491
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Sensitivity and Specificity
- Risk Assessment
- Research
- Practice Guidelines as Topic
- Physical Fitness
- Pharmaceutical Preparations
- Outcome Assessment, Health Care
- Male